Inclusion Criteria:

- Male aged 21 years or older.

- Ability to provide signed informed consent and willingness to comply with protocol
requirements.

- Past biopsy indicating the presence of adenocarcinoma of the prostate gland.

- Participant is deemed to have tissue suspicious of prostate cancer involvement that
is amenable to biopsy/resection.

- Have had, or will undergo diagnostic CT or MRI imaging prior to surgery.

- Participants must agree to use an acceptable form of birth control throughout the
study period. Participants must use condoms for a period of seven days after study
drug administration, if engaged in sexual activity.

Exclusion Criteria:

- Participants for whom participating would significantly delay the scheduled standard
of care therapy.

- Participants administered a radioisotope within 5 physical half lives prior to study
enrollment.

- Participants with any medical condition or other circumstances that, in the opinion
of the investigator, would significantly decrease obtaining reliable data, achieving
study objectives or completing the study.